Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine

被引:238
|
作者
Stumpf, Julian [1 ,40 ]
Siepmann, Torsten [2 ]
Lindner, Tom [3 ]
Karger, Claudia [4 ]
Schwoebel, Joerg [5 ]
Anders, Leona [6 ]
Faulhaber-Walter, Robert [7 ]
Schewe, Jens [8 ]
Martin, Heike [9 ]
Schirutschke, Holger [10 ]
Barnett, Kerstin [11 ]
Huether, Jan [12 ]
Mueller, Petra [13 ]
Langer, Torsten [14 ]
Pluntke, Thilo [15 ]
Anding-Rost, Kirsten [16 ]
Meistring, Frank [17 ]
Stehr, Thomas [18 ]
Pietzonka, Annegret [19 ]
Escher, Katja [20 ]
Cerny, Simon [21 ]
Rothe, Hansjorg [22 ]
Pistrosch, Frank [23 ]
Seidel, Harald [24 ]
Paliege, Alexander [1 ]
Beige, Joachim [4 ,25 ]
Bast, Ingolf [6 ]
Steglich, Anne [1 ]
Gembardt, Florian [1 ]
Kessel, Friederike [1 ]
Kroeger, Hannah [1 ]
Arndt, Patrick [1 ]
Sradnick, Jan [1 ]
Frank, Kerstin [26 ]
Klimova, Anna [27 ]
Mauer, Rene [28 ]
Graehlert, Xina [29 ]
Anft, Moritz [30 ,31 ]
Blazquez-Navarro, Arturo [30 ,31 ]
Westhoff, Timm H. [32 ]
Stervbo, Ulrik [30 ,31 ]
Tonn, Torsten [33 ,34 ]
Babel, Nina [30 ,31 ,35 ,36 ,37 ,38 ,39 ]
Hugo, Christian [1 ,40 ]
机构
[1] Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Med Klin & Poliklin 3, Dresden, Germany
[2] Krankenhaus Kuhwald, KfH Nierenzentrum, Klinikum Chemnitz, Dresden, Germany
[3] Univ Hosp Leipzig, Div Nephrol, Leipzig, Germany
[4] Klinikum St Georg, KfH Nierenzentrum, Leipzig, Germany
[5] Dialysezenturm Chemnitz, Chemnitz, Germany
[6] Dialysepraxis Leipzig, Leipzig, Germany
[7] Nephrol Zentrum Freiberg, Freiberg, Germany
[8] Dialyse & Nierenambulanz Sebnitz, Sebnitz, Germany
[9] Nephrol Zentrum Zwickau, Zwickau, Germany
[10] PHV Dialysezentrum Dresden Friedrichstadt, Dresden, Germany
[11] Dialyse Heidenau, Heidenau, Germany
[12] Nephrocare GmbH Dobeln, Dobeln, Germany
[13] PHV Dialysezentrum Dresden Johannstadt, Dresden, Germany
[14] Dialysezentrum Annaberg, Annaberg Buchholz, Germany
[15] KfH Nierenzentrum Grimma, Grimma, Germany
[16] KfH Nierenzentrum Bischofswerda, Bischofswerda, Germany
[17] Stadt Klinikum Gorlitz, KfH Nierenzentrum, Gorlitz, Germany
[18] KfH Nierenzentrum Bautzen, Bautzen, Germany
[19] Via Medis Nierenzentrum Dresden MVZ GmbH, Dresden, Germany
[20] KfH Gesundheitszentrum Aue, Aue Bad Schlema, Germany
[21] ELBLAND Dialyse Grossenhain, Grossenhain, Germany
[22] Dialyse Praxis Weiwasser, Weiwasser, Germany
[23] Nephrol Zentrum Hoyerswerda, Hoyerswerda, Germany
[24] Vogtland Krankenhaus Plauen, KfH Nierenzentrum, Plauen, Germany
[25] Martin Luther Univ Halle Wittenberg, Dept Nephrol & Rheumatol, Internal Med 2, Halle, Germany
[26] DRK Blutspendedienst Nord Ost Gemeinnutzige GmbH, Inst Transfus Med Plauen, Plauen, Germany
[27] Natl Ctr Tumor Dis NCT, Partner Site Dresden, Dresden, Germany
[28] Tech Univ, Fac Med Carl Gustav Carus, Inst Med Informat & Biometry IMB, Dresden, Germany
[29] Coordinating Ctr Clin Trials, Dresden, Germany
[30] Ruhr Univ Bochum, Ctr Translat Med, Med Dept 1, Marien Hosp Herne,Univ Hosp, Bochum, Germany
[31] Ruhr Univ Bochum, Univ Hosp, Marien Hosp Herne, Med Dept 1,Immune Diagnost Lab, Bochum, Germany
[32] Ruhr Univ Bochum, Marien Hosp Herne, Med Dept 1, Univ Hosp, Herne, Germany
[33] German Red Cross Blood Donat Serv North East, Inst Transfus Med, Dresden, Germany
[34] Tech Univ, Fac Med Carl Gustav Carus, Transfus Med, Dresden, Germany
[35] Charite Univ Med Berlin, Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany
[36] Free Univ Berlin, Berlin, Germany
[37] Humboldt Univ, Berlin, Germany
[38] Berlin Inst Hlth, Berlin, Germany
[39] Inst Med Immunol, Berlin, Germany
[40] KfH Nierenzentrum Dresden, Dresden, Germany
来源
LANCET REGIONAL HEALTH-EUROPE | 2021年 / 9卷
关键词
epidemiology; COVID-19; SARS-CoV-2; vaccination; mRNA-1273; BNT162b2; tozinameran; dialysis patients; kidney transplant recipients; medical personnel; humoral and cellular immune response; clinical decision-making; guidelines; COVID-19; RECIPIENTS; SPIKE;
D O I
10.1016/j.lanepe.2021.100178
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Dialysis and kidney transplant patients are vulnerable populations for COVID-19 related disease and mortality. Methods: We conducted a prospective study exploring the eight week time course of specific cellular (interferon-g release assay and flow cytometry) or/and humoral immune responses (ELISA) to SARS-CoV-2 boost vaccination in more than 3100 participants including medical personnel, dialysis patients and kidney transplant recipients using mRNA vaccines BNT162b2 or mRNA-1273. Results: SARS-CoV-2-vaccination induced seroconversion efficacy in dialysis patients was similar to medical personnel (> 95%), but markedly impaired in kidney transplant recipients (42%). T-cellular immunity largely mimicked humoral results. Major risk factors of seroconversion failure were immunosuppressive drug number and type (belatacept, MMF-MPA, calcineurin-inhibitors) as well as vaccine type (BNT162b2 mRNA). Seroconversion rates induced by mRNA-1273 compared to BNT162b2 vaccine were 97% to 88% (p < 0.001) in dialysis and 49% to 26% in transplant patients, respectively. Specific IgG directed against the new binding domain of the spike protein (RDB) were significantly higher in dialysis patients vaccinated by mRNA-1273 (95%) compared to BNT162b2 (85%, p < 0.001). Vaccination appeared safe and highly effective demonstrating an almost complete lack of symptomatic COVID-19 disease after boost vaccination as well as ceased disease incidences during third pandemic wave in dialysis patients. Conclusion: Dialysis patients exhibit a remarkably high seroconversion rate of 95% after boost vaccination, while humoral response is impaired in the majority of transplant recipients. Immunosuppressive drug number and type as well as vaccine type (BNT162b2) are major determinants of seroconversion failure in both dialysis and transplant patients suggesting immune monitoring and adaption of vaccination protocols. (C) 2021 The Authors. Published by Elsevier Ltd.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Humoral and Cellular Immunity Are Significantly Affected in Renal Transplant Recipients, following Vaccination with BNT162b2
    Fylaktou, Asimina
    Stai, Stamatia
    Kasimatis, Efstratios
    Xochelli, Aliki
    Nikolaidou, Vasiliki
    Papadopoulou, Anastasia
    Myserlis, Grigorios
    Lioulios, Georgios
    Asouchidou, Despoina
    Giannaki, Maria
    Yannaki, Evangelia
    Tsoulfas, Georgios
    Papagianni, Aikaterini
    Stangou, Maria
    VACCINES, 2023, 11 (11)
  • [42] The temporal course of T- and B-cell responses to vaccination with BNT162b2 and mRNA-1273
    Markewitz, Robert
    Pauli, Daniela
    Dargvainiene, Justina
    Steinhagen, Katja
    Engel, Sarah
    Herbst, Victor
    Zapf, Dorinja
    Krueger, Christina
    Sharifzadeh, Shahpour
    Schomburg, Benjamin
    Leypoldt, Frank
    Rupp, Jan
    Goerg, Siegfried
    Junker, Ralf
    Wandinger, Klaus-Peter
    CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (05) : 701 - 709
  • [43] Induction of immune response after SARS-CoV-2 mRNA BNT162b2 vaccination in healthcare workers
    Zaffina, Salvatore
    Alteri, Claudia
    Ruggiero, Alessandra
    Cotugno, Nicola
    Vinci, Maria Rosaria
    Camisa, Vincenzo
    Santoro, Anna Paola
    Brugaletta, Rita
    Deriu, Gloria
    Mortari, Eva Piano
    Salinas, Ane Fernandez
    Russo, Cristina
    Ranno, Stefania
    Coltella, Luana
    Colagrossi, Luna
    Porzio, Ottavia
    Muda, Andrea Onetti
    Raponi, Massimiliano
    degli Atti, Marta Ciofi
    Rizzo, Caterina
    Villani, Alberto
    Rossi, Paolo
    Palma, Paolo
    Carsetti, Rita
    Perno, Carlo Federico
    JOURNAL OF VIRUS ERADICATION, 2021, 7 (02)
  • [44] Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patients
    Becker, Matthias
    Cossmann, Anne
    Luerken, Karsten
    Junker, Daniel
    Gruber, Jens
    Juengling, Jennifer
    Ramos, Gema Morillas
    Beigel, Andrea
    Wrenger, Eike
    Lonnemann, Gerhard
    Stankov, Metodi, V
    Dopfer-Jablonka, Alexandra
    Kaiser, Philipp D.
    Traenkle, Bjoern
    Rothbauer, Ulrich
    Krause, Gerard
    Schneiderhan-Marra, Nicole
    Strengert, Monika
    Dulovic, Alex
    Behrens, Georg M. N.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [45] Effect of SARS-CoV-2 Infection and BNT162b2 Vaccination on the mRNA Expression of Genes Associated with Angiogenesis
    Wigner-Jeziorska, Paulina
    Janik-Karpinska, Edyta
    Niwald, Marta
    Saluk, Joanna
    Miller, Elzbieta
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (22)
  • [46] Impaired Humoral Immunity with Concomitant Preserved T Cell Reactivity in IBD Patients on Treatment with Infliximab 6 Month after Vaccination with the SARS-CoV-2 mRNA Vaccine BNT162b2: A Pilot Study
    Vollenberg, Richard
    Tepasse, Phil-Robin
    Lorentzen, Eva
    Nowacki, Tobias Max
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (05):
  • [47] Four cases of acquired hemophilia A following immunization with mRNA BNT162b2 SARS-CoV-2 vaccine
    Leone, Maria Cristina
    Canovi, Simone
    Pilia, Annalisa
    Casali, Annamaria
    Depietri, Luca
    Fasano, Tommaso
    Colla, Rossana
    Ghirarduzzi, Angelo
    THROMBOSIS RESEARCH, 2022, 211 : 60 - 62
  • [48] Risk factors for SARS-CoV-2 infection after primary vaccination with ChAdOx1 nCoV-19 or BNT162b2 and after booster vaccination with BNT162b2 or mRNA-1273: A population-based cohort study (COVIDENCE UK)
    Vivaldi, Giulia
    Jolliffe, David A.
    Holt, Hayley
    Tydeman, Florence
    Talaei, Mohammad
    Davies, Gwyneth A.
    Lyons, Ronan A.
    Griffiths, Christopher J.
    Kee, Frank
    Sheikh, Aziz
    Shaheen, Seif O.
    Martineau, Adrian R.
    LANCET REGIONAL HEALTH-EUROPE, 2022, 22
  • [49] Central diabetes insipidus: a late sequela of BNT162b2 SARS-CoV-2 mRNA vaccine?
    Ishay, Avraham
    Shacham, Elena Chertok
    BMC ENDOCRINE DISORDERS, 2023, 23 (01)
  • [50] Humoral response to mRNA anti-COVID-19 vaccines BNT162b2 and mRNA-1273 in patients with chronic lymphocytic leukemia
    Bagacean, Cristina
    Letestu, Remi
    Al-Nawakil, Chadi
    Brichler, Segolene
    Levy, Vincent
    Sritharan, Nanthara
    Delmer, Alain
    Dartigeas, Caroline
    Leblond, Veronique
    Roos-Weil, Damien
    Tomowiak, Cecile
    Merabet, Fatiha
    Bene, Marie C.
    Clavert, Aline
    Chaoui, Driss
    Genet, Philippe
    Guieze, Romain
    Laribi, Kamel
    Drenou, Bernard
    Willems, Lise
    Puppinck, Christian
    Legendre, Hugo
    Troussard, Xavier
    Malartre, Stephanie
    Cymbalista, Florence
    Michallet, Anne-Sophie
    BLOOD ADVANCES, 2022, 6 (01) : 207 - 211